1.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 4 to 6 and 15 to 25 Sponsor: Pharmaceutical / Industry Protocol IDs: 115887, 2011-005604-15, NCT01627561
|
|
2.
|
Phase: Phase III Type: Prevention Status: Active Age: 16 to 26 Sponsor: Pharmaceutical / Industry Protocol IDs: V503-003, 2012-001375-36, NCT01651949
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 13 to 26 Sponsor: NCI, Other Protocol IDs: CDR0000685816, AMC-072, U01CA121947, NCT01209325
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: JHOC-J0656, J0656, NA_00002176, NCT00788164
|